Abbott Laboratories logo

Abbott Laboratories (ABL)

Market Open
5 Dec, 10:01
XBER XBER
107. 58
+0.4
+0.37%
- Market Cap
36.49 P/E Ratio
2.2% Div Yield
0 Volume
4.44 Eps
107.18
Previous Close
Day Range
107.28 107.58
Year Range
103.7 134.34
Want to track ABL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 47 days
Abbott Laboratories logo
ABL Abbott Laboratories
21 Jan 2026 (In 1 month)
1.5
Cons. EPS
-
EPS
Abbott Laboratories logo
ABL Abbott Laboratories
15 Oct 2025
1.3
Cons. EPS
-
EPS
Abbott Laboratories logo
ABL Abbott Laboratories
14 Oct 2025
-
Cons. EPS
-
EPS
Abbott Laboratories logo
ABL Abbott Laboratories
16 Jul 2025
-
Cons. EPS
-
EPS
Abbott Laboratories logo
ABL Abbott Laboratories
15 Apr 2025
-
Cons. EPS
-
EPS
Abbott Laboratories logo
ABL Abbott Laboratories
22 Jan 2025
-
Cons. EPS
-
EPS
Abbott Laboratories logo
ABL Abbott Laboratories
16 Oct 2024
-
Cons. EPS
-
EPS
Abbott Laboratories logo
ABL Abbott Laboratories
18 Jul 2024
-
Cons. EPS
-
EPS
Abbott Laboratories logo
ABL Abbott Laboratories
17 Apr 2024
-
Cons. EPS
-
EPS
Abbott Laboratories logo
ABL Abbott Laboratories
24 Jan 2024
-
Cons. EPS
-
EPS
Abbott Laboratories logo
ABL Abbott Laboratories
18 Oct 2023
-
Cons. EPS
-
EPS

ABL Earnings Reports FAQ

What is the earnings per share (EPS) for ABL?

The current EPS is 4.44.

What is the company's earnings growth rate?

Abbott Laboratories has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-01-21, based on the ABL's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Abbott Laboratories are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for ABL at this time, as Abbott Laboratories has no recent EPS data to calculate it.